Upcoming Login Downtime

We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.

For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Management Tracks

Scott Leffler named CFO at Myriad

Plus: Brian MacDonald retires as chief innovation officer at Disc, and updates from BioAgeis and Sofinnova Partners

December 22, 2023 2:02 AM UTC

Scott Leffler will become CFO of  Myriad Genetics Inc. (NASDAQ:MYGN) on Jan. 29 following the retirement of CFO Bryan Riggsbee, who will continue as strategic adviser until March 31. Leffler was CFO at Clover Health and Sotera Health Co. (NASDAQ:SHC). 

Brian MacDonald is retiring as chief innovation officer of  Disc Medicine Inc. (NASDAQ:IRON) and will become chair of its scientific advisory board. Disc is developing therapies for serious hematological diseases...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article